Dr. Barney S. Graham

powered by
COS Expertise®
National Institute of Health (NIH)
Viral Pathogenesis Laboratory and Clinical Trials Core
Vaccine Research Center
Senior InvestigatorAppointed: 2000
Professional Headshot of Barney S. Graham

Mailing Address

Vaccine Research Center/NIAID/NIH
Building 40, Room 2502
40 Convent Drive
MSC 3017
Bethesda, Maryland 20892-3017
United States

Contact Information

Phone: (301) 594-8468
Fax: (301) 480-2771
bgraham@nih.gov

Qualifications

Ph.D., Vanderbilt University, Microbiology and Immunology, 1991.
Fellow, Vanderbilt University, Infectious Diseases, 1986.
Chief Residency, Vanderbilt University Hospital, Internal Medicine, 1984.
Chief Residency, Nashville General Hospital, Internal Medicine, 1983.
Internship and Residency, Vanderbilt University, Internal Medicine, 1982.
M.D., University of Kansas, 1979.
B.A., Rice University, Biology, 1975.

Expertise and Research Interests

The Viral Pathogenesis Laboratory focuses on the immunopathogenesis of respiratory syncytial virus and development of new vaccine platforms for viral diseases. Major projects include: 1) Defining the role of the RSV G glycoprotein in modulating early immune responses and dendritic cell function, 2) Defining molecular mechanisms that alter CD8+ T cell phenotype and function to change the balance of viral clearance and immunopathology, 3) Defining gene-based vaccine delivery approaches that optimize T cell-mediated viral clearance and minimize immunopathology, 4) development of a vaccine for RSV.

The Clinical Trials Core performs Phase I trials of candidate HIV vaccines developed by the VRC. This involves community education on HIV prevention, recruitment of healthy adults into clinical trials, study design and analysis, and maintenance of regulatory standards. The Clinical Studies Core also conducts studies on the natural history of HIV infection and evaluates basic aspects of pathogenesis, antigen presentation, and immune response. In addition, clinical trails for alternative smallpox vaccines, Ebola virus, West Nile virus, SARS coronavirus, and H5 influenza virus have been conducted by the VRC.

Keywords

COS Keywords:

AIDS, Clinical Trial, HIV, Immunology, Pathogenesis, Respiratory System, Vaccine, Virology.

Additional Terms:

Acquired Immune Deficiency Syndrome (AIDS), Enhanced Illness, Human Immunodeficiency Virus (HIV), Immunology, Mouse Model, Pathogenesis, Respiratory Syncytial Virus, Vaccine, Vaccinia, Virology.

Memberships

American Academy of Microbiology
American Association of Immunologists
American College of Physicians
American Society for Clinical Investigation
American Society for Microbiology
Association of American Physicians
Infectious Diseases Society of America

Honors and Awards

1993, The Grant Liddle Research Appreciation Award, Housestaff from all Departments, Vanderbilt University, for promoting interest in research among young physicians
1992, One of twelve Nashville physicians honored by a donated sculpture, Dr. Felix A. Fly, St. Thomas Hospital, Nashville, Tennessee
1979-1979, Roscoe Falls Morton Award, Wichita Campus, University of Kansas, Outstanding Senior Student in Internal Medicine

Previous Positions

1999-2000, Associate Professor, Vanderbilt University, School of Medicine, Microbiology and Immunology
1996-2000, Professor, Vanderbilt University, Medicine, Medicine, Infectious Diseases
1992-1996, Associate Professor, Vanderbilt University, School of Medicine, Medicine, Infectious Diseases
1992-1999, Assistant Professor, Vanderbilt University, School of Medicine, Microbiology and Immunology
1986-1992, Assistant Professor, Vanderbilt University, School of Medicine, Medicine, Infectious Diseases

Publications

  • Tavel JA, Martin JE, Kelly GG, Enama ME, Shen JM, Gomez PL, Andrews CA, Koup RA, Bailer RT, Stein JA, Roederer M, Nabel GJ, Graham BS (2007) Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1 seronegative subjects, Journal of Acquired Immune Deficiency Syndromes (44), 601-6
  • Russell ND, Graham BS, Keefer M, McElrath MJ, Self S, Deers M, Chiu J, Weinhold K, Montefiori D, Ferrari G, Horton H, Gurunathan S, Baglyos L, Frey S, Goepfert P, Harro C, Buchbinder S, Baden L, Blattner W, Koblin BA, Corey L, the NIAID HIV Vaccine Trials Network (2007) Phase II study of an HIV-1 canarypox vaccine (vcp 1452), alone and in combination with rgp 120: Negative results fail to trigger a Phase III correlates trial, Journal of Acquired Immune Deficiency Syndromes (44), 203-12
  • Parrino J, McCurdy LH, Larkin BD, Gordon IJ, Rucker SE, Enama ME, Koup RA, Roederer M, Bailer RT, Moodie Z, Gu L, Yan L, Graham BS (2007) Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naive and vaccinia-immune individuals, Vaccine (25), 1513-25
  • Johnson JE, Gonzales R, Olson SJ, Wright PF, Graham BS (2006) The histopathology of fatal untreated human respiratory syncytial virus infection, Modern Pathology (20), 108-19
  • Parrino J, Graham BS (2006) Smallpox vaccines: Past, present, and future, Journal of Allergy and Clinical Immunology (118), 1320-6
  • Graham BS (2006) New approaches to vaccine adjuvants: Inhibiting the inhibitor, PLoS Medicine (3), 18-20
  • Zhou W, Hashimoto K, Moore ML, Elias JA, Zhu Z, Durbin J, Colasurdo G, Rutigliano JA, Chiappetta CL, Goleniewska K, O'Neal JF, Graham BS, Peebles RS (2006) IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse, Microbes and Infection (8), 2880-89
  • Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA, Bailer RT, Chakrabarti BK, Bailery MA, Gomez PL, Andrews CA, Moodie Z, Gu L, Stein JA, Nabel GJ, Graham BS, the VRC 204 Study Team (2006) A DNA vaccine for Ebola virus is safe and immunogenic in a Phase I clinical trial, Clinical and Vaccine Immunology (13), 1267-77
  • Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JGD, King CR, Andrews CA, Sheets R, Gomez PL, Mascola JR, Nabel GJ, Graham BS, the VRC 006 Study Team (2006) Phase I safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenoviral vector, Journal of Infectious Diseases (194), 1638-49
  • Graham BS, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Martin JE, McCluskey MM, Chakrabarti BK, Lamoreaux L, Andrews CA, Gomez PL, Mascola JR, Nabel GJ, the VRC 004 Study Team (2005) Phase I safety and immunogenicity evaluation of a multiclade HIV-1 candidate DNA vaccine, Journal of Infectious Diseases (194), 1650-60
  • Khurana S, Needham J, Park S, Mathieson B, Busch MP, Nemo G, Nyambi P, Zolla-Pazner S, Laal S, Mulenga J, Chomba E, Hunter E, Allen S, McIntyre J, Hewlett I, Lee S, Tang S, Cowan E, Beyrer C, Altfeld M, Yu X, Tounkara A, Koita O, Rodriguez-Chavez IR, Nguyen N, Graham BS, Todd D, Mugenyi P, Ketter N, Fast P, Golding H (2006) HIV-SELECTEST - A novel assay for diagnosis of HIV infections in the face of vaccine generated antibodies: Utility for detection of diverse HIV-1 subtypes, Journal of Acquired Immune Deficiency Syndromes (43), 304-12
  • Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hyrniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G (2006) Subunit recombinant vaccine protects against monkeypox, Journal of Immunology (177), 2552-64
  • Khurana S, Needham J, Mathieson B, Chavez IR, Catanzaro AT, Bailer RT, Kim J, Polonis V, Cooper DA, Guerin J, Peterson ML, Gurwith M, Nguyen N, Graham BS, Golding H, the HIV Vaccine Trials Network (2006) HIV vaccine trials: A novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies in participants, Journal of Virology (80), 2092-9
  • Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, Kolls JK, Dubin PJ, Sheller JR, Goleniewska K, O'Neal JF, Olson SJ, Mitchell D, Graham BS, Peebles RS Jr (Sep 2005) Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels., The Journal of Allergy and Clinical Immunology, 116 (3), 550-7 Abstract
  • Rutigliano JA, Rock MT, Johnson AK, Crowe JE Jr, Graham BS (Jul 2005) Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus., Virology, 337 (2), 335-43 Abstract
  • Gower TL, Pastey MK, Peeples ME, Collins PL, McCurdy LH, Hart TK, Guth A, Johnson TR, Graham BS (May 2005) RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology., Journal of Virology, 79 (9), 5326-36 Abstract
  • Graham BS, Mascola JR, Lessons from failure--preparing for future HIV-1 vaccine efficacy trials., The Journal of Infectious Diseases, 191(5), 647-9, Mar 2005 Abstract
  • Peebles RS, Hashimoto K, Sheller JR, Morrow JD, Ji S, Elias J, Goleniewska K, O'Neal J, Mitchell DB, Graham BS, Zhou W (2005) Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent., Journal of Immunology (175), 8253-9
  • Peebles RS Jr, Graham BS (2005) Pathogenesis of respiratory syncytial virus infection in the murine model., Proc Am Thorac Soc, 2 (2), 110-5 Abstract
  • Hashimoto K, Sheller JR, Morrow JD, Collins RD, Goleniewska K, O'Neal J, Zhou W, Ji S, Mitchell DB, Graham BS, Peebles RS Jr (Jan 2005) Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms., Journal of Immunology (baltimore, Md. : 1950), 174 (1), 525-32 Abstract
  • Agwale SM, Tanimoto L, Womack C, Odama L, Leung K, Duey D, Negedu-Momoh R, Audu I, Mohammed SB, Inyang U, Graham B, Ziermann R (Dec 2004) Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes., Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology., 31 Suppl 1, S3-6 Abstract
  • Schmidt AC, Johnson TR, Openshaw PJ, Braciale TJ, Falsey AR, Anderson LJ, Wertz GW, Groothuis JR, Prince GA, Melero JA, Graham BS (Nov 2004) Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003., Virus Research, 106 (1), 1-13 Abstract
  • McCurdy LH, Rutigliano JA, Johnson TR, Chen M, Graham BS (Nov 2004) Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4., Journal of Virology, 78 (22), 12471-9 Abstract
  • Hashimoto K, Graham BS, Geraci MW, FitzGerald GA, Egan K, Zhou W, Goleniewska K, O'Neal JF, Morrow JD, Durbin RK, Wright PF, Collins RD, Suzutani T, Peebles RS Jr (Oct 2004) Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness., Journal of Virology, 78 (19), 10303-9 Abstract
  • Rutigliano JA, Graham BS (Sep 2004) Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection., Journal of Immunology (baltimore, Md. : 1950), 173 (5), 3408-17 Abstract
  • Lee D, Graham BS, Chiu YL, Gilbert PB, McElrath MJ, Belshe RB, Buchbinder SP, Sheppard HW, Koblin BA, Mayer KH, Keefer MC, Mulligan MJ, Celum CL (Sep 2004) Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160., The Journal of Infectious Diseases, 190 (5), 903-7 Abstract
  • Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, Olson SJ, Zhou W, Suzutani T, Jones PW, Goleniewska K, O'Neal JF, Peebles RS Jr (Aug 2004) Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5., American Journal of Respiratory and Critical Care Medicine, 170 (3), 306-12 Abstract
  • Budge PJ, Graham BS (Aug 2004) Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses., The Journal of Antimicrobial Chemotherapy, 54 (2), 299-302 Abstract
  • Johnson TR, Varga SM, Braciale TJ, Graham BS (Aug 2004) Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV., Journal of Virology, 78 (16), 8753-60 Abstract
  • McCurdy LH, Larkin BD, Martin JE, Graham BS (Jun 2004) Modified vaccinia Ankara: potential as an alternative smallpox vaccine., Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America., 38 (12), 1749-53 Abstract
  • Johnson TR, Teng MN, Collins PL, Graham BS (Jun 2004) Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV., Journal of Virology, 78 (11), 6024-32 Abstract
  • Budge PJ, Li Y, Beeler JA, Graham BS (May 2004) RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G., Journal of Virology, 78 (10), 5015-22 Abstract
  • Rutigliano JA, Johnson TR, Hollinger TN, Fischer JE, Aung S, Graham BS, Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection, Journal of Virology, 78(6), 3014-23, 2004 Abstract
  • Johnson TR, Graham BS, Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection, The Pediatric Infectious Disease Journal, 23(1 Suppl), S46-57, 2004 Abstract
  • Johnson TR, Graham BS (Jan 2004) Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection., The Pediatric Infectious Disease Journal, 23 (1 Suppl), S46-57 Abstract
  • Tang YW, Johnson JE, Browning PJ, Cruz-Gervis RA, Davis A, Graham BS, Brigham KL, Oates JA Jr, Loyd JE, Stecenko AA, Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis, Journal of Clinical Microbiology, 41(6), 2633-40, 2003 Abstract
  • McCurdy LH, Graham BS, Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation, Journal of Virology, 77(3), 1747-56, 2003 Abstract
  • Johnson TR, Parker RA, Johnson JE, Graham BS, IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge, Journal of Immunology (Baltimore, MD: 1950), 170(4), 2037-45, February 2003
  • Peebles RS Jr, Hashimoto K, Graham BS, The complex relationship between respiratory syncytial virus and allergy in lung disease, Viral Immunology, 16(1), 25-34, 2003 Abstract
  • Lee CG, Homer RJ, Cohn L, Link H, Jung S, Craft JE, Graham BS, Johnson TR, Elias JA, Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways, Journal of Bioligical Chemistry, 277(38), 35466-74, 2002 Abstract
  • Hashimoto K, Peebles RS Jr, Sheller JR, Jarzecka K, Furlong J, Mitchell DB, Hartert TV, Graham BS, Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor, Thorax, 57(6), 524-7, 2002 Abstract
  • Graham BS, Rutigliano JA, Johnson TR, Respiratory syncytial virus immunobiology and pathogenesis, Virology, 297(1), 1-7, 2002 Abstract
  • Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS, NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus, Journal of Virology, 76(9), 4294-303, 2002 Abstract
  • Wright PF, Gruber WC, Peters M, Reed G, Zhu Y, Robinson F, Coleman-Dockery S, Graham BS, Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus, The Journal of Infectious Diseases, 185(8), 1011-8, 2002 Abstract
  • Peebles RS Jr, Hashimoto K, Morrow JD, Dworski R, Collins RD, Hashimoto Y, Christman JW, Kang KH, Jarzecka K, Furlong J, Mitchell DB, Talati M, Graham BS, Sheller JR, Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice, American Journal of Respiratory and Critical Care Medicine, 165(8), 1154-60, 2002 Abstract
  • Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS, The role of IFN in respiratory syncytial virus pathogenesis, Journal of Immunology (Baltimore, MD: 1950), 168(6), 2944-52, March 2002
  • Graham BS, Clinical trials of HIV vaccines, Annual Review of Medicine, 53, 207-21, 2002 Abstract
  • Peebles RS Jr, Hashimoto K, Collins RD, Jarzecka K, Furlong J, Mitchell DB, Sheller JR, Graham BS, Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges, The Journal of Infectious Diseases, 184(11), 1374-9, 2001 Abstract
  • Bredenberg HK, Graham BS, Hospitalization costs of respiratory syncytial virus infection, The Pediatric Infectious Disease Journal, 20(11), 1100-1, 2001 Abstract
  • Aung S, Rutigliano JA, Graham BS, Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease, Journal of Virology, 75(20), 9918-24, 2001 Abstract
  • Johnson TR, Fischer JE, Graham BS, Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine, Journal of General Virology, 82(Pt 9), 2107-16, 2001 Abstract
  • Gower TL, Peeples ME, Collins PL, Graham BS, RhoA is activated during respiratory syncytial virus infection, Virology, 283(2), 188-96, 2001 Abstract
  • Gower TL, Graham BS, Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro, Antimicrobial Agents and Chemotherapy, 45(4), 1231-7, 2001 Abstract
  • Peebles RS Jr, Sheller JR, Collins RD, Jarzecka AK, Mitchell DB, Parker RA, Graham BS, Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice, Journal of Medical Virology, 63(2), 178-88, February 2001 Abstract
  • Evans TG, McElrath MJ, Matthews T, Montefiori D, Weinhold K, Wolff M, Keefer MC, Kallas EG, Corey L, Gorse GJ, Belshe R, Graham BS, Spearman PW, Schwartz D, Mulligan MJ, Goepfert P, Fast P, Berman P, Powell M, Francis D, NIAID AIDS Vaccine Evaluation Group, QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans, Vaccine, 19(15-16), 2080-91, 2001 Abstract
  • Peebles RS Jr, Graham BS, Viruses, dendritic cells and the lung, Respiratory Research, 2(4), 245-9, 2001 Abstract
  • Fischer JE, Johnson JE, Johnson TR, Graham BS, Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection, Journal of Infectious Diseases, 182(4), 1029-38, October 2000 Abstract
  • Fischer JE, Johnson JE, Johnson TR, Graham BS (Oct 2000) Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection., The Journal of Infectious Diseases, 182 (4), 1029-38 Abstract
  • Peebles RS, Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Graham BS, Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV, Journal of Infectious Diseases, 182(3), 671-7, September 2000 Abstract
  • Peebles RS Jr, Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Graham BS (Sep 2000) Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV., The Journal of Infectious Diseases, 182 (3), 671-7 Abstract
  • Stokes Peebles R Jr, Dworski R, Collins RD, Jarzecka K, Mitchell DB, Graham BS, Sheller JR, Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice, American Journal of Respiratory and Critical Care Medicine, 162(2 Pt 1), 676-81, August 2000 Abstract
  • Graham BS, Johnson TR, Peebles RS, Immune-mediated disease pathogenesis in respiratory syncytial virus infection, Immunopharmacology, 48(3), 237-47, 2000 Abstract
  • Graham BS, Johnson TR, Peebles RS (Jul 2000) Immune-mediated disease pathogenesis in respiratory syncytial virus infection., Immunopharmacology, 48 (3), 237-47 Abstract
  • Graham BS, Johnson TR, Peebles RS (Jul 2000) Immune-mediated disease pathogenesis in respiratory syncytial virus infection., Immunopharmacology, 48 (3), 237-47 Abstract
  • McElrath MJ, Corey L, Montefiori D, Wolff M, Schwartz D, Keefer M, Belshe R, Graham BS, Matthews T, Wright P, Gorse G, Dolin R, Berman P, Francis D, Duliege AM, Bolognesi D, Stablein D, Ketter N, Fast P, A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group, Aids Research and Human Retroviruses, 16(9), 907-19, June 2000 Abstract
  • Aung S, Graham BS, IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo, Journal of Immunology, 164(7), 3487-93, April 2000 Abstract
  • Pastey MK, Gower TL, Spearman PW, Crowe JE Jr, Graham BS (Jan 2000) A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3., Nature Medicine, 6 (1), 35-40 Abstract
  • Aung S, Tang YW, Graham BS (Nov 1999) Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo., Journal of Virology, 73 (11), 8944-9 Abstract
  • Johnson TR, Graham BS (Oct 1999) Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism., Journal of Virology, 73 (10), 8485-95 Abstract
  • Fisher RG, Crowe JE Jr, Johnson TR, Tang YW, Graham BS (Oct 1999) Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus., The Journal of Infectious Diseases, 180 (4), 1324-7 Abstract
  • Fisher RG, Johnson JE, Dillon SB, Parker RA, Graham BS (Sep 1999) Prophylaxis with respiratory syncytial virus F-specific humanized monoclonal antibody delays and moderately suppresses the native antibody response but does not impair immunity to late rechallenge., The Journal of Infectious Diseases, 180 (3), 708-13 Abstract
  • Fischer JE, Johnson TR, Peebles RS, Graham BS (Sep 1999) Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge., The Journal of Infectious Diseases, 180 (3), 714-9 Abstract
  • Pastey MK, Crowe JE Jr, Graham BS (Sep 1999) RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation., Journal of Virology, 73 (9), 7262-70 Abstract
  • Evans TG, Keefer MC, Weinhold KJ, Wolff M, Montefiori D, Gorse GJ, Graham BS, McElrath MJ, Clements-Mann ML, Mulligan MJ, Fast P, Walker MC, Excler JL, Duliege AM, Tartaglia J (Aug 1999) A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers., The Journal of Infectious Diseases, 180 (2), 290-8 Abstract
  • Gicheru MM, Otsyula M, Spearman P, Graham BS, Miller CJ, Robinson HL, Haigwood NL, Montefiori DC (Jun 1999) Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm)., Journal of Medical Primatology, 28 (3), 97-104 Abstract
  • Peebles RS Jr, Sheller JR, Johnson JE, Mitchell DB, Graham BS (Feb 1999) Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice., Journal of Medical Virology, 57 (2), 186-92 Abstract
  • Walsh EE, Graham BS, Respiratory Syncytial Virus (Chapter 7), 161-203, 1999
  • McElrath MJ, Corey L, Montefiori D, Wolff M, Clements ML, Dolin R, Belshe R, Graham BS, Matthews T, Francis D, Duliege AM, Bolognesi D, Stablein D, Walker MC, Fast P, the AIDS Vaccine Evaluation Group, A Phase II study of two HIV-1 gp120 subunit vaccines comparing their immunogenicity and effect on sexual activity in populations at risk for acquiring HIV-1 infection, AIDS Research and Human Retroviruses, 1999
  • Graham BS, Infection with HIV-1, Bmj (clinical Research Ed.), 317(7168), 1297-301, November 1998 Abstract
  • Clements-Mann ML, Weinhold K, Matthews TJ, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Hsieh RH, Mestecky J, Zolla-Pazner S, Mascola J, Schwartz D, Siliciano R, Corey L, Wright PF, Belshe R, Dolin R, Jackson S, Xu S, Fast P, Walker MC, Stablein D, Excler JL, Tartaglia J, Paoletti E, Et Al. (May 1998) Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group., The Journal of Infectious Diseases, 177 (5), 1230-46 Abstract
  • Johnson TR, Johnson JE, Roberts SR, Wertz GW, Parker RA, Graham BS, Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge, Journal of Virology, 72(4), 2871-80, April 1998 Abstract
  • Johnson TR, Johnson JE, Roberts SR, Wertz GW, Parker RA, Graham BS, Priming with secreted glycoprotein G of respiratory syncytial virus \(RSV\) augments interleukin-5 production and tissue eosinophilia after RSV challenge., Journal of Virology, 72(4), 2871-80, 1998 Abstract
  • Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF, Korber BT, Wolff MC, Fast PE, Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection, Journal of Infectious Diseases, 177(2), 310-9, February 1998 Abstract
  • Connor RI, Korber BT, Graham BS, Hahn BH, Ho DD, Walker BD, Neumann AU, Vermund SH, Mestecky J, Jackson S, Fenamore E, Cao Y, Gao F, Kalams S, Kunstman KJ, McDonald D, McWilliams N, Trkola A, Moore JP, Wolinsky SM, Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines, Journal of Virology, 72(2), 1552-76, February 1998 Abstract
  • Corey L, McElrath MJ, Weinhold K, Matthews T, Stablein D, Graham B, Keefer M, Schwartz D, Gorse G, Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group, Journal of Infectious Diseases, 177(2), 301-9, February 1998 Abstract
  • Graham BS, Karzon DT, AIDS Vaccine Development (Second Edition Chapter 42), 689-724, 1998
  • Fischer JE, Johnson JE, Kuli-Zade RK, Johnson TR, Aung S, Parker RA, Graham BS, Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus, Journal of Virology, 71(11), 8672-7, November 1997 Abstract
  • Fischer JE, Johnson JE, Kuli-Zade RK, Johnson TR, Aung S, Parker RA, Graham BS, Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus., Journal of Virology, 71(11), 8672-7, November 1997 Abstract
  • Keefer MC, Wolff M, Gorse GJ, Graham BS, Corey L, Clements-Mann ML, Verani-Ketter N, Erb S, Smith CM, Belshe RB, Wagner LJ, McElrath MJ, Schwartz DH, Fast P, Safety profile of phase I and II preventive HIV type 1 envelope vaccination: Experience of the NIAID AIDS Vaccine Evaluation Group, Aids Research and Human Retroviruses, 13(14), 1163-77, September 1997
  • Tang YW, Graham BS, T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice, Journal of Clinical Investigation, 99(9), 2183-91, May 1997 Abstract
  • Neuzil KM, Johnson JE, Tang YW, Prieels JP, Slaoui M, Gar N, Graham BS, Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine, Vaccine, 15(5), 525-32, April 1997 Abstract
  • Pincus SH, Messer KG, Cole R, Ireland R, VanCott TC, Pinter A, Schwartz DH, Graham BS, Gorse GJ, Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccines, Journal of Immunology, 158(7), 3511-20, April 1997 Abstract
  • Tang YW, Neuzil KM, Fischer JE, Robinson FW, Parker RA, Graham BS, Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus, Vaccine, 15(6-7), 597-602, 1997 Abstract
  • Graham BS, Keefer MC, McElrath MJ, Gorse GJ, Schwartz DH, Weinhold K, Matthews TJ, Esterlitz JR, Sinangil F, Fast PE, Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group, Annals of Internal Medicine, 125(4), 270-9, August 1996 Abstract
  • Lindgren C, Lin J, Graham BS, Gray ME, Parker RA, Sundell HW, Respiratory syncytial virus infection enhances the response to laryngeal chemostimulation and inhibits arousal from sleep in young lambs, Acta Paediatrica, 85(7), 789-97, July 1996 Abstract
  • Graham BS, Immunological determinants of disease caused by respiratory syncytial virus, Trends in Microbiology, 4(7), 290-3, July 1996 Abstract
  • Neuzil KM, Tang YW, Graham BS, Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo, American Journal of the Medical Sciences, 311(5), 201-4, May 1996 Abstract
  • Keefer MC, Graham BS, McElrath MJ, Matthews TJ, Stablein DM, Corey L, Wright PF, Lawrence D, Fast PE, Weinhold K, Hsieh RH, Chernoff D, Dekker C, Dolin R, Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group, Aids Research and Human Retroviruses, 12(8), 683-93, May 1996 Abstract
  • Tang YW, Graham BS, Potential for directing appropriate responses to vaccines by cytokine manipulation, Clinical Immunotherapeutics, 5, 327-333, 1996
  • Neuzil KM, Graham BS, Cytokines and innate immunity in respiratory viral infection, Seminars in Virology, 7, 255-264, 1996
  • Graham BS, Wright PF, Candidate AIDS vaccines, New England Journal of Medicine, 333(20), 1331-9, November 1995 Abstract
  • Graham BS, Pathogenesis of respiratory syncytial virus vaccine-augmented pathology, American Journal of Respiratory and Critical Care Medicine, 152(4 Pt 2), S63-6, October 1995 Abstract
  • Tang YW, Graham BS, Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity, Journal of Infectious Diseases, 172(3), 734-8, September 1995 Abstract
  • Graham BS, Tang YW, Gruber WC, Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin, Journal of Infectious Diseases, 171(6), 1468-74, June 1995 Abstract
  • Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Graham BS, Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections, Antimicrobial Agents and Chemotherapy, 39(5), 1191-3, May 1995 Abstract
  • Keefer MC, Graham BS, Belshe RB, Schwartz D, Corey L, Bolognesi DP, Stablein DM, Montefiori DC, McElrath MJ, Clements ML, et al, Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network, Aids Research and Human Retroviruses, 10(12), 1713-23, December 1994 Abstract
  • Neuzil KM, Mitchell HC, Loyd JE, Lagerstrom CF, Hammon JW Jr, Graham BS, Extrapulmonary thoracic disease caused by Blastomyces dermatitidis, Chest, 106(6), 1885-7, December 1994 Abstract
  • Gorse GJ, Schwartz DH, Graham BS, Matthews TJ, Stablein DM, Frey SE, Belshe RB, Clements ML, Wright PF, Eibl M, et al, HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network, Clinical and Experimental Immunology, 98(2), 178-84, November 1994 Abstract
  • Tang YW, Graham BS, Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus, Journal of Clinical Investigation, 94(5), 1953-8, November 1994 Abstract
  • Belshe RB, Clements ML, Keefer MC, Graham BS, Corey L, Sposto R, Wescott S, Lawrence D, Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials Group, Annals of Internal Medicine, 121(8), 584-9, October 1994 Abstract
  • Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R, et al, Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases, Journal of Infectious Diseases, 170(4), 782-6, October 1994 Abstract
  • Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, Dolin R, Matthews T, Weinhold K, Bolognesi DP, Sposto R, et al, Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network [see comments], Jama, 272(6), 475-80, August 1994 Abstract
  • Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM, Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS, Journal of Infectious Diseases, 170(2), 429-32, August 1994 Abstract
  • Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Engelhardt B, Graham BS, Serum vitamin A levels in respiratory syncytial virus infection, Journal of Pediatrics, 124(3), 433-6, March 1994 Abstract
  • Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Engelhardt B, Graham BS, Serum vitamin A levels in respiratory syncytial virus infection [see comments, Journal of Pediatrics, 124(3), 433-6, 1994 Abstract
  • Graham BS, Serological responses to candidate AIDS vaccines, Aids Research and Human Retroviruses, 10 Suppl 2, S145-8, 1994 Abstract
  • Belshe RB, Clements ML, Dolin R, Graham BS, McElrath J, Gorse GJ, Schwartz D, Keefer MC, Wright P, Corey L, et al, Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Disea, Journal of Infectious Diseases, 168(6), 1387-95, December 1993 Abstract
  • Hesselton RM, Koup RA, Cromwell MA, Graham BS, Johns M, Sullivan JL, Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution, Journal of Infectious Diseases, 168(3), 630-40, September 1993 Abstract
  • Graham BS, Davis TH, Tang YW, Gruber WC, Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum, Pediatric Research, 34(2), 167-72, August 1993 Abstract
  • Graham BS, Henderson GS, Tang YW, Lu X, Neuzil KM, Colley DG, Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus, Journal of Immunology, 151(4), 2032-40, August 1993 Abstract
  • Pincus SH, Messer KG, Schwartz DH, Lewis GK, Graham BS, Blattner WA, Fisher G, Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees, Journal of Clinical Investigation, 91(5), 1987-96, May 1993 Abstract
  • Graham BS, Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP, et al, Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical, Journal of Infectious Diseases, 167(3), 533-7, March 1993 Abstract
  • Edwards KM, Decker MD, Graham BS, Mezzatesta J, Scott J, Hackell J, Adult immunization with acellular pertussis vaccine, Jama, 269(1), 53-6, January 1993 Abstract
  • Montefiori DC, Graham BS, Zhou JT et al, V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fuion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 biniding si, Journal of Clinical Investigation, 92, 840-847, 1993
  • Lagerstrom CF, Mitchell HG, Graham BS, Hammon JW Jr, Chronic fibrosing mediastinitis and superior vena caval obstruction from blastomycosis, Annals of Thoracic Surgery, 54(4), 764-5, October 1992 Abstract
  • Ukwu HN, Graham BS, Lambert JS, Wright PF, Perinatal transmission of human immunodeficiency virus-1 infection and maternal immunization strategies for prevention, Obstetrics and Gynecology, 80(3 Pt 1), 458-68, September 1992 Abstract
  • Graham BS, Clinical trials of AIDS vaccines in seronegative volunteers: vectors and combinations, Aids Research and Human Retroviruses, 8(8), 1327-8, August 1992 Abstract
  • Graham BS, Belshe RB, Clements ML, Dolin R, Corey L, Wright PF, Gorse GJ, Midthun K, Keefer MC, Roberts NJ Jr, et al, Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Net, Journal of Infectious Diseases, 166(2), 244-52, August 1992 Abstract
  • Lindgren C, Jing L, Graham B, Grogaard J, Sundell H, Respiratory syncytial virus infection reinforces reflex apnea in young lambs, Pediatric Research, 31(4 Pt 1), 381-5, April 1992 Abstract
  • Graham BS, Bunton LA, Wright PF, Karzon DT, Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice, Journal of Clinical Investigation, 88(3), 1026-33, September 1991 Abstract
  • Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT, Respiratory syncytial virus infection in anti-mu-treated mice, Journal of Virology, 65(9), 4936-42, September 1991 Abstract
  • Graham BS, Bunton LA, Wright PF, Karzon DT, Reinfection of mice with respiratory syncytial virus [published erratum appears in J Med Virol 1991 Dec;35(4):307], Journal of Medical Virology, 34(1), 7-13, May 1991 Abstract
  • Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, et al, The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network, Annals of Internal Medicine, 114(2), 119-27, January 1991 Abstract
  • Graham BS, Rowland JM, Modliszewski A, Montefiori DC, Antifusion activity in sera from persons infected with human immunodeficiency virus type 1, Journal of Clinical Microbiology, 28(12), 2608-11, December 1990 Abstract
  • Graham BS, Wetherall NT, Growth of human cell lines in BALB/c mice, Cancer Research, 50(18), 5943-6, September 1990 Abstract
  • Graham BS, Karzon DT, Development of an AIDS vaccine. Biological and ethical challenges, Infectious Disease Clinics of North America, 4(2), 223-43, June 1990 Abstract
  • Graham BS, Perkins MD, Wright PF, Karzon DT, Primary respiratory syncytial virus infection in mice, Journal of Medical Virology, 26(2), 153-62, October 1988 Abstract
  • Hendry RM, Burns JC, Walsh EE, Graham BS, Wright PF, Hemming VG, Rodriguez WJ, Kim HW, Prince GA, McIntosh K, et al, Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus, Journal of Infectious Diseases, 157(4), 640-7, April 1988 Abstract
  • Murphy BR, Alling DW, Snyder MH, Walsh EE, Prince GA, Chanock RM, Hemming VG, Rodriguez WJ, Kim HW, Graham BS, et al, Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection, Journal of Clinical Microbiology, 24(5), 894-8, November 1986 Abstract
  • Wagner DK, Graham BS, Wright PF, Walsh EE, Kim HW, Reimer CB, Nelson DL, Chanock RM, Murphy BR, Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection, Journal of Clinical Microbiology, 24(2), 304-6, August 1986 Abstract
  • Murphy BR, Graham BS, Prince GA, Walsh EE, Chanock RM, Karzon DT, Wright PF, Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection, Journal of Clinical Microbiology, 23(6), 1009-14, June 1986 Abstract
  • Adkins RB Jr, Maples MD, Graham BS, Witt TT, Davies J, Dysphagia associated with an aortic arch anomaly in adults, American Surgeon, 52(5), 238-45, May 1986 Abstract
  • Graham BS, Lichtenstein MJ, Hinson JM, Theil GB, Nonexertional heatstroke. Physiologic management and cooling in 14 patients, Archives of Internal Medicine, 146(1), 87-90, January 1986 Abstract
  • George AL Jr, Hays JT, Graham BS, Blastomycosis presenting as monoarticular arthritis. The role of synovial fluid cytology, Arthritis and Rheumatism, 28(5), 516-21, May 1985 Abstract
  • Maples MD, Adkins RB Jr, Graham BS, Dao AH, Scott HW Jr, Pseudotumor of the lung, American Surgeon, 51(2), 84-8, February 1985 Abstract
  • Graham BS, Detection of bacteremia and fungemia: microscopic examination of peripheral blood smears, Infection Control, 5(9), 448-52, September 1984 Abstract
  • Graham BS, Tucker WS Jr, Opportunistic infections in endogenous Cushing's syndrome, Annals of Internal Medicine, 101(3), 334-8, September 1984 Abstract
  • Graham BS, Hinson MV, Bennett SR, Gregory DW, Schaffner W, Acid-fast bacilli on buffy coat smears in the acquired immunodeficiency syndrome: a lesson from Hansen's bacillus, Southern Medical Journal, 77(2), 246-8, February 1984 Abstract
  • Graham BS, Snell JD Jr, Herpes simplex virus infection of the adult lower respiratory tract, Medicine, 62(6), 384-93, November 1983 Abstract
  • Cook B, O'Sullivan F, Leung J, Morse P, Graham B, Chapman AL, Transformation of human embryo cells with the use of cell-free extracts of a human rhabdomyosarcoma cell line (HUS-2): brief communication, Journal of the National Cancer Institute, 60(5), 979-84, May 1978 Abstract
  • Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, Harari A, Pantaleo G, Bailer R, Graham BS, Roederer M, Koup R, Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses, Journal of Experimental Medicine, In Press
  • Catanzaro AT, Roederer M, Koup RA, Bailer RT, Enama ME, Nason MC, Martin JE, Rucker S, Andrews CA, Gomez PL, Mascola JR, nabel GJ, Graham BS, Phase I clinical evaluation of a six--plasmid multiclade HIV-1 DNA candidate vaccine, Vaccine, In Press
  • Rutigliano JA, Ruckwardt TJ, Martin JE, Graham BS, Distinct epitope-specific CD8+ T cell phenotypes and functional hierarchy in a hybrid mouse model of respiratory syncytial virus infection, Virology, In Press

Profile Details

Last Updated: 5/7/2007

COS Expertise ID #303406
Reference this profile directly: http://myprofile.cos.com/barneygraham